MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

  • About
  • Blog
  • Privacy Policy
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

Balance Sheets Overview

Current Ratio
916.94%
Quick Ratio
916.94%
Cash Ratio
275.01%
Debt to Asset Ratio
17.73%
Unit: Thousand (K) dollars
Assets Breakdown
    • Marketable securities
    • Cash and cash equivalents
    • Operating lease right-of-use ass...
    • Others
Liabilities Breakdown
    • Additional paid-in capital
    • Accumulated deficit
    • Operating lease liabilities - no...
    • Others

Balance Sheets
2026-03-31
Cash and cash equivalents
160,575
Marketable securities
356,066
Restricted cash and cash equivalents (vie)
0
Prepaid expenses and other current assets
18,749
Total current assets
535,390
Total property and equipment
79,367
Less accumulated depreciation
51,530
Property and equipment, net
27,837
Operating lease right-of-use assets
57,765
Other assets
4,745
Total assets
625,737
Accounts payable
7,617
Accrued expenses and other current liabilities
19,267
Deferred revenue - current
17,244
Current portion of finance lease liabilities
3,883
Operating lease liabilities - current
10,378
Total current liabilities
58,389
Warrant to purchase convertible preferred stock
0
Finance lease liabilities, net of current portion
2,221
Deferred revenue - non-current
1,238
Operating lease liabilities - non-current
49,088
Other long term liabilities
0
Total liabilities
110,936
Convertible preferred stock
0
Non-controlling interest
0
Common stock, 0.001 par value 500,000,000 and 200,456,735 shares authorized as of march 31, 2026 and december 31, 2025 respectively 128,192,522 and 33,116,957 shares issued and outstanding as of march 31, 2026 and december 31, 2025, respectively
128
Additional paid-in capital
1,252,388
Accumulated other comprehensive income
24
Accumulated deficit
-737,739
Total stockholders' equity (deficit)
514,801
Total liabilities, convertible preferred stock, non-controlling interests and stockholders' equity (deficit)
625,737
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Balance Sheets

Marketable securities$356,066K Cash and cashequivalents$160,575K Prepaid expenses andother current assets$18,749K Total property andequipment$79,367K Total current assets$535,390K Operating leaseright-of-use assets$57,765K Property and equipment,net$27,837K Other assets$4,745K Less accumulateddepreciation$51,530K Total assets$625,737K Total liabilities,convertible preferred...$625,737K Total stockholders'equity (deficit)$514,801K Total liabilities$110,936K Accumulated deficit-$737,739K Additional paid-in capital$1,252,388K Total currentliabilities$58,389K Operating leaseliabilities - non-current$49,088K Finance leaseliabilities, net of current...$2,221K Deferred revenue -non-current$1,238K Common stock, 0.001 parvalue 500,000,000 and...$128K Accumulated othercomprehensive income$24K Accrued expenses andother current...$19,267K Deferred revenue -current$17,244K Operating leaseliabilities - current$10,378K Accounts payable$7,617K Current portion offinance lease...$3,883K

Generate Biomedicines, Inc. (GENB)

Generate Biomedicines, Inc. (GENB)